Hu Kun, Song Yun-He, Lin Feng-Bin, Zhang Ying-Zhe, Jin Ling, Liang Meng-Yin, Weinreb Robert N, Zhang Xiu-Lan
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou 510060, Guangdong Province, China.
Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego, La Jolla, CA 92093, USA.
Int J Ophthalmol. 2023 Jul 18;16(7):1071-1077. doi: 10.18240/ijo.2023.07.11. eCollection 2023.
To evaluate the safety and efficacy of posterior scleral application (a modified technique) of an antimetabolite mitomycin C-soaked sponge in trabeculectomy for patients with glaucoma.
This retrospective study included 101 patients (115 eyes) with glaucoma (aged 12-83y) who underwent trabeculectomy using a modified mitomycin C-soaked sponge placement method. A piece of 3.5×10 mm sponge was placed vertically and posteriorly with the long side perpendicular to the limbus. The mitomycin C concentration and exposure time were 0.2-0.5 mg/mL and 1-5min, respectively. Intraocular pressure, best-corrected visual acuity, and hypotensive medications were recorded at baseline and at the final visit. Complications, interventions required, and bleb morphology were recorded postoperatively. The primary outcome was trabeculectomy safety, including complications and bleb morphology; the secondary outcome was the trabeculectomy success rate.
At the final follow-up [median 28mo, range 7-67mo and interquartile range (IQR) 13mo], the qualified (cumulative) success rate was 93.0% and the complete success rate was 60.0%. No bleb-related complications were observed. The mean height, extent, and vascularity grades were 0.6±0.9, 1.1±0.4, and 2.4±0.9, respectively. All Seidel tests were negative. The mean posteriority grade was 0.8±0.4.
Trabeculectomy with the long side of a mitomycin C-soaked sponge placed perpendicular to the corneal limbus is safe and effective.
评估抗代谢物丝裂霉素C浸泡海绵后巩膜应用(一种改良技术)在青光眼小梁切除术中的安全性和有效性。
这项回顾性研究纳入了101例(115只眼)青光眼患者(年龄12 - 83岁),他们接受了使用改良丝裂霉素C浸泡海绵放置方法的小梁切除术。将一块3.5×10毫米的海绵垂直并向后放置,长边垂直于角膜缘。丝裂霉素C的浓度和暴露时间分别为0.2 - 0.5毫克/毫升和1 - 5分钟。在基线和最后一次随访时记录眼压、最佳矫正视力和降压药物使用情况。术后记录并发症、所需干预措施和滤过泡形态。主要结局是小梁切除术的安全性,包括并发症和滤过泡形态;次要结局是小梁切除术的成功率。
在最后一次随访时[中位数28个月,范围7 - 67个月,四分位间距(IQR)13个月],合格(累积)成功率为93.0%,完全成功率为60.0%。未观察到与滤过泡相关的并发症。平均高度、范围和血管化程度分级分别为0.6±0.9、1.1±0.4和2.4±0.9。所有Seidel试验均为阴性。平均后位分级为0.8±0.4。
丝裂霉素C浸泡海绵长边垂直于角膜缘放置的小梁切除术是安全有效的。